Evaluation of a Nutritional Technology for Vitamin D Absorption

Exclusion Criteria

• •Use of vitamin D or calcium supplements within 3 weeks prior to the Screening Visit.
• •Use of a tanning booth/lamp within 3 weeks prior to the Screening Visit.
• •Travel to sunny location within 3 weeks prior to the Screening Visit.
• •Consumption of more than 3 alcoholic drinks per day starting 48 hours before the Screening Visit.
• •Has an allergy or intolerance to any ingredient in the study product.
• •Participating in another study that has not been approved as a concomitant study by Abbott Nutrition.
• •Use of the following medications that may have interactions with vitamin D absorption or metabolism:
• •* Aluminum-containing phosphate binders
• •* Anticonvulsants
• •* Atorvastatin
• •* Calcipotriene
• •* Cholestyramine
• •* Cytochrome P-450 3A4 substrates
• •* Digoxin
• •* Diltiazem
• •* Orlistat
• •* Thiazide diuretics
• •* Corticosteroids
• •* Stimulant laxatives
• •* Verapamil